← Back to Search

Radiation Therapy

Stereotactic Body Radiation Therapy plus Surgery for Non-Small Cell Lung Cancer

N/A
Waitlist Available
Led By David Palma, MD, PhD
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2.5 years
Awards & highlights

Study Summary

This trial will help researchers know if SABR can help treat non-small cell lung cancer by killing cancer cells and making surgery more effective.

Eligible Conditions
  • Non-Small Cell Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2.5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2.5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Tumor response
Secondary outcome measures
Predictive value of imaging biomarkers
Quality of life measures , including physical well-being, functional well-being, and lung-cancer subscale questions
Toxicity of the combined approach of SABR + surgery
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Stereotactic Body Radiation Therapy plus SurgeryExperimental Treatment1 Intervention
Stereotactic body radiation therapy followed by surgical resection
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Stereotactic Body Radiation Therapy plus Surgery
2014
N/A
~40

Find a Location

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor
659 Previous Clinical Trials
413,692 Total Patients Enrolled
David Palma, MD, PhDPrincipal InvestigatorLondon Regional Cancer Program of the Lawson Health Research Institute
3 Previous Clinical Trials
196 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung Cancer
David Palma 2014. "A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02136355.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top